Literature DB >> 26025702

The Relationship of Bone Mineral Density to Oxidant/Antioxidant Status and Inflammatory and Bone Turnover Markers in a Multicenter Cross-Sectional Study of Young Men with Ankylosing Spondylitis.

Le Wang1, Liangbin Gao, Dan Jin, Peng Wang, Bo Yang, Wen Deng, Zhongyu Xie, Yong Tang, Yanfeng Wu, Huiyong Shen.   

Abstract

Low bone mineral density (BMD) is an important complication of ankylosing spondylitis (AS) that seriously affects men and their quality of life, even in young patients. However, the relationships among redox; levels of bone turnover markers (BTMs), inflammatory markers and disease activity; and low BMD in AS require clarification. We recruited 102 men aged 30-39 year with AS and 102 healthy, sex- and age-matched controls for this cross-sectional study. The subjects were analyzed for lumbar spine and femoral neck BMD by dual-energy X-ray absorptiometry. Significantly lower BMD and corresponding T-scores were observed in the AS patients compared with the controls (P < 0.05). The oxidant biomarker and antioxidant levels were significantly (P < 0.05) higher and lower, respectively, in the AS subjects compared with the controls, and the bone resorption and inflammatory marker levels were higher (P < 0.05). In subgroup analyses, the patients with osteoporosis or active disease had the highest levels of oxidant biomarkers (P < 0.05). Furthermore, the BMD T-scores in AS were found to be negatively correlated with oxidative status (P < 0.05). Multivariate binary logistic analysis showed that low BMD in the AS patients was associated with higher levels of advanced oxidation protein products, malondialdehyde and C-terminal telopeptide of type I collagen; lower levels of glutathione peroxidase; and higher scores of a bath ankylosing spondylitis metrology index. In conclusion, imbalanced redox was independently associated with low BMD in young men with AS and may play an important role in the pathogenesis of AS-related low BMD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26025702     DOI: 10.1007/s00223-015-0001-x

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

Review 1.  Bone Involvement in Patients with Spondyloarthropathies.

Authors:  Willem Lems; Corinne Miceli-Richard; Judith Haschka; Andrea Giusti; Gitte Lund Chistensen; Roland Kocijan; Nicolas Rosine; Niklas Rye Jørgensen; Gerolamo Bianchi; Christian Roux
Journal:  Calcif Tissue Int       Date:  2022-01-23       Impact factor: 4.333

2.  Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis.

Authors:  Guiwen Ye; Zhongyu Xie; Huiqiong Zeng; Peng Wang; Jinteng Li; Guan Zheng; Shan Wang; Qian Cao; Ming Li; Wenjie Liu; Shuizhong Cen; Zhaofeng Li; Yanfeng Wu; Zhizhong Ye; Huiyong Shen
Journal:  Cell Death Dis       Date:  2020-09-17       Impact factor: 8.469

3.  WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis.

Authors:  Sungsin Jo; Subin Weon; Bora Nam; Mi-Ae Jang; Hyundeok Kang; Tae-Jong Kim; Ye-Soo Park; Tae-Hwan Kim
Journal:  Arthritis Res Ther       Date:  2021-12-08       Impact factor: 5.156

4.  New Insights into the Regulatory Role of Ferroptosis in Ankylosing Spondylitis via Consensus Clustering of Ferroptosis-Related Genes and Weighted Gene Co-Expression Network Analysis.

Authors:  Tianhua Rong; Ningyi Jia; Bingxuan Wu; Dacheng Sang; Baoge Liu
Journal:  Genes (Basel)       Date:  2022-07-31       Impact factor: 4.141

5.  The relationship of ischemia-modified albumin levels to disease activity scores and HLA-B27 in patients with ankylosing spondylitis.

Authors:  Filiz Meryem Sertpoyraz; Ayfer Colak; Aylin Dikici; Nihan Erdinc Gunduz; Merve Zeytinli Aksit
Journal:  North Clin Istanb       Date:  2020-11-24

Review 6.  Haptoglobin and Its Related Protein, Zonulin-What Is Their Role in Spondyloarthropathy?

Authors:  Magdalena Chmielińska; Marzena Olesińska; Katarzyna Romanowska-Próchnicka; Dariusz Szukiewicz
Journal:  J Clin Med       Date:  2021-03-08       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.